Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Mar 15;62(4):55. doi: 10.3892/ijo.2023.5503

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © Guo et al.

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

PMC Copyright notice

Expression of ALK1 and ID1 at different time points in each group. (A) Expression of ALK1 at different time points (0, 2, 3, 6, 10 and 24 h) in the control, PDT, K02288 and PDT + K02288 groups. (B) Expression of ALK1 at 2 h in the control, NC, PDT, Ad-ALK1 and PDT + Ad-ALK1 groups. (C) Expression of ID1 at different time points (0, 2, 3, 6, 10 and 24 h) in the control, PDT, K02288 and PDT + K02288 groups. (D) Expression of ID1 at 2 h in the control, NC, PDT, Ad-ALK1 and Ad-ALK1 + PDT groups. ^*P<0.05, ^**P<0.01, ^***P<0.001 and ^****P<0.0001. NC, negative control; Ad, adenovirus; PDT, photodynamic therapy; ALK1, activin receptor-like kinase-1; ID1, inhibitor of DNA binding 1.